Lepra is a pioneering **Health Care** startup dedicated to providing health, inclusion, and innovation for individuals affected by leprosy and lymphatic filariasis (LF). The organization's mission is further underscored by the esteemed patronage of **His Majesty King Charles III**. With a founding date of **1924**, Lepra remains steadfast in its commitment to addressing the ongoing challenges presented by these diseases. The company's profound impact is evident in the staggering statistics: each day, 500 individuals receive a leprosy diagnosis, with 28 of those being children. Moreover, over **3 million people** worldwide are currently living with undiagnosed leprosy. These numbers serve as a poignant reminder that leprosy is not a relic of the past, but a present-day reality that continues to wreak havoc on countless lives. For those interested in delving deeper into Lepra's initiatives and impact, the organization's **website (lepra.org.uk)** serves as a valuable resource. Additionally, Lepra fosters ongoing engagement through its active presence on various social media platforms, including **Facebook (facebook.com/LepraUK)**, **Twitter (twitter.com/LepraUK)**, and **Instagram (@LepraUK)**. As of the latest available data, there is no specific information regarding Lepra's recent investment activities or affiliated investors. Nevertheless, the company's unwavering commitment to its cause, under the patronage of His Majesty King Charles III, positions it as a compelling entity within the realm of health-focused startups.
There is no investment information
No recent news or press coverage available for Lepra.